Back to search

United States· US:71335-3170_9dc82071-76f4-47c2-b293-346b14b0c804

Tetracycline Hydrochloride

A tetracycline product containing tetracycline hydrochloride, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 9 of our 19 countries.

ATC J01AA07

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTetracycline HydrochlorideATCJ01AA07REGISTER NO.US:71335-3170_9dc8207…PACKS LISTED8CHECKEDSeptember 27, 2026

Where it is registered

Tetracycline is registered in 9 of 19 countries.

Countries holding a registration under ATC J01AA07 (tetracycline), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Tetracycline · ATC J01AA07

9 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TETRACYCLINE HYDROCHLORIDE
Manufacturer
Bryant Ranch Prepack
Country
United States (US)
ATC code
J01AA07
ATC class
Tetracycline
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    71335-3170-1
  • ndc11
    71335-3170-2
  • ndc11
    71335-3170-3
  • ndc11
    71335-3170-4
  • ndc11
    71335-3170-5
  • ndc11
    71335-3170-6
  • ndc11
    71335-3170-7
  • ndc11
    71335-3170-8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

359 interactions on record for tetracycline.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tetracycline · interactions on record

359 records

  • 11 severe
  • 131 moderate
  • 33 minor
  • 184 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tetracycline in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetracycline products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Belgium · Tetralysal
  • Bulgaria · Тетрациклин Абр, Тетрациклин Актавис
  • Cyprus · Medocycline
  • Denmark · Tetracyclin Actavis, Tetracyklin "dak"
  • Finland · Oricyclin
  • France · Tetralysal
  • United Kingdom (Northern Ireland) · Economycin, Tetracycline
  • Greece · Muvito, Tetrac
  • Italy · Ambramicina, Tetralysal
  • Luxembourg · Tetralysal
  • Netherlands · Tetracycline Hcl Cf
  • Norway · Tetracyclin Actavis, Tetralysal
  • Poland · Tetracyclinum Chema, Tetracyclinum Tzf
  • Romania · Tetraciclină Arena, Tetraciclina Atb
  • Sweden · Tetralysal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ef8ccf0f-9da6-492a-8922-d070668e267f
GET /v1/drugs/ef8ccf0f-9da6-492a-8922-d070668e267f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "TETRACYCLINE HYDROCHLORIDE",
  "productndc": "71335-3170",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA062752",
  "marketing_category": "ANDA"
}

See everything about tetracycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.